Issues Magazine

Issues Magazine 96

A glimpse into this edition of Issues.
What’s the point of protecting intellectual property? Christine Emmanuel outlines its origins and her experiences in the science IP profession.
Australians can be proud of inventions like the Victa lawn mower and the cochlear implant, but how does our scientific innovation fare in a global sense? Changes to Australian patent law aim to help researchers and innovators achieve success in their own country.
Dangerous uncharted waters lie ahead if our politicians vote to support the proposed amendment of Australia’s Patents Act to ban patents on biological materials and genes.
In late July, the Court of Appeals for the US Federal Circuit held that human genes are patentable subject matter. The ramifications of this decision have yet to be felt in Australia. Are our politicians prepared to stand up to the biotechnology industry and pass the Amendment Bill into law?
The Patent Amendment (Human Genes and Biological Materials) Bill was introduced to the Senate late last year and immediately referred to a new Senate Inquiry. The Bill’s contents have escalated concerns about this long-running and complex debate.
New technology is untangling the complex network of patents at the centre of a litigation war between smartphone companies.
Philip Soos proposes a new system whereby the government directly finances research and development, and all drugs are produced as generics at market-competitive prices.
The first step to protecting your creative and intellectual effort is to identify and classify your intellectual property to determine the most appropriate way to protect it.
Nearly half of the academic scientists in a recent study reported that their choice of research projects had been affected by the presence of other parties’ patents. Issues with patent permissions and the culture of the workplace have the largest influence over whether or not patents affect the direction of research.
Take note: poor laboratory notebook documentation could cost you! Your laboratory notebooks can be critical in establishing your rights to an invention.
What is copyright and who really benefits from it? The open access alternative challenges the rationale of copyright and side-steps powerful interests.
Public and private sector individuals invest many hours and large sums of money developing new crop varieties, but how do they protect those investments?
Myriad Genetics is continuing to defend its patents for genes involved in breast cancer even though the US Supreme Court rules they were invalid.
US President Barack Obama has announced reforms to the US patent system to combat the dramatic rise in legal claims from Non-Practising Entities .
Tthe Australian Parliament is debating a bill on patent law reforms that will improve access to cancer testing and treatment and essential medicines for diseases such as HIV/AIDS, tuberculosis and malaria.